JP3102921B2 - Medical device and method of manufacturing medical device - Google Patents

Medical device and method of manufacturing medical device

Info

Publication number
JP3102921B2
JP3102921B2 JP03216386A JP21638691A JP3102921B2 JP 3102921 B2 JP3102921 B2 JP 3102921B2 JP 03216386 A JP03216386 A JP 03216386A JP 21638691 A JP21638691 A JP 21638691A JP 3102921 B2 JP3102921 B2 JP 3102921B2
Authority
JP
Japan
Prior art keywords
medical device
tube
tubular
vinyl chloride
caprolactam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP03216386A
Other languages
Japanese (ja)
Other versions
JPH0615006A (en
Inventor
川 俊 二 市
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kawasumi Laboratories Inc
Original Assignee
Kawasumi Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kawasumi Laboratories Inc filed Critical Kawasumi Laboratories Inc
Priority to JP03216386A priority Critical patent/JP3102921B2/en
Publication of JPH0615006A publication Critical patent/JPH0615006A/en
Application granted granted Critical
Publication of JP3102921B2 publication Critical patent/JP3102921B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G10MUSICAL INSTRUMENTS; ACOUSTICS
    • G10LSPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
    • G10L19/00Speech or audio signals analysis-synthesis techniques for redundancy reduction, e.g. in vocoders; Coding or decoding of speech or audio signals, using source filter models or psychoacoustic analysis
    • G10L2019/0001Codebooks
    • G10L2019/0003Backward prediction of gain
    • GPHYSICS
    • G10MUSICAL INSTRUMENTS; ACOUSTICS
    • G10LSPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
    • G10L19/00Speech or audio signals analysis-synthesis techniques for redundancy reduction, e.g. in vocoders; Coding or decoding of speech or audio signals, using source filter models or psychoacoustic analysis
    • G10L2019/0001Codebooks
    • G10L2019/0011Long term prediction filters, i.e. pitch estimation

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、血液バッグ、血液回路
等のなどの管状部品同士を接続して構成される塩化ビニ
ル樹脂製医療器具および該医療器具の製造方法に関す
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a medical device made of a vinyl chloride resin, which is formed by connecting tubular parts such as a blood bag and a blood circuit, and a method of manufacturing the medical device.

【0002】[0002]

【従来技術および発明が解決しようとする課題】一般に
血液バッグ、血液回路等のなどの管状部品同士を接続し
て構成される医療器具は、安全性、加工性及び材料費な
どの点から塩化ビニル樹脂から形成されている。
2. Description of the Related Art Generally, a medical device constructed by connecting tubular parts such as a blood bag and a blood circuit is made of vinyl chloride in terms of safety, workability and material cost. It is formed from resin.

【0003】塩化ビニル樹脂製管状部品同士の接続は、
高周波ウェルダ−を用いて管状部品の接続部を融着する
方法や、複雑な構造や径の異なるチュ−ブを挿入して接
続する場合は、塩化ビニル樹脂を溶解させる溶剤とし
て、テトラヒドロフランやシクロヘキサノンが用いられ
ている。
The connection between tubular parts made of vinyl chloride resin is as follows:
In the case of connecting a tubular part using a high-frequency welder or connecting a tube having a complicated structure or a different diameter, tetrahydrofuran or cyclohexanone is used as a solvent for dissolving the vinyl chloride resin. Used.

【0004】しかしながら、高周波ウェルダ−を用いて
接続する方法は、部品同士が管状である場合には、芯金
が挿入できず外部からの高周波の発振のみとなり充分な
溶着強度が得られなかった。また溶剤を用いる方法で
は、溶剤が部品内に残留し、体液と接する場合があるの
で衛生上好ましくない。
However, in the method of connecting using a high-frequency welder, when the parts are tubular, the core cannot be inserted, and only high-frequency oscillation from the outside occurs, and sufficient welding strength cannot be obtained. In addition, the method using a solvent is not preferable in terms of hygiene because the solvent may remain in the parts and come into contact with body fluid.

【0005】また、特開昭60−63063号公報に開
示されているように、可塑剤を配合してなる塩化ビニル
重合体ペ−ストレジンを管状部品の接続部に充填した
後、熱滅菌により加熱してペ−ストレジンを固化するこ
とによって接続部を接着する方法が提案されているが、
重合体ペ−ストレジンは、塩化ビニルラテックスを可塑
剤を用いて液の中に分散させたプラチゾルが不安定でレ
ジンの沈降が生じやすく調整が困難とか、加熱温度によ
っても接着強度が大きく左右されるという課題があっ
た。そこで本発明者は以上の課題を解決するために鋭意
検討を重ねた結果次の発明に到達した。
Further, as disclosed in Japanese Patent Application Laid-Open No. Sho 60-63063, a vinyl chloride polymer paste resin containing a plasticizer is filled into a connection portion of a tubular component, and then heated by heat sterilization. Then, a method of bonding the connection portion by solidifying the paste resin has been proposed,
The adhesive strength of the polymer paste resin is greatly affected by the heating temperature and the difficulty in adjusting the resin because the plastisol in which vinyl chloride latex is dispersed in a liquid using a plasticizer is unstable and sedimentation of the resin is likely to occur. There was a problem that. The inventor of the present invention has made intensive studies in order to solve the above-mentioned problems, and has arrived at the following invention.

【0006】[0006]

【課題を解決するための手段】図1は、医療器具の該略
図で、接続チュ−ブ2とY字管3(いずれも塩化ビニル
樹脂製の管状部材)の接着面にε−カプロラクタムを含
む可塑剤溶液を塗布して、これを加熱滅菌(乾燥)処理
を施して接続したものである(4はε−カプロラクタム
接着剤)。
FIG. 1 is a schematic view of a medical device, in which .epsilon.-caprolactam is attached to the connecting surface of a connecting tube 2 and a Y-shaped tube 3 (both are tubular members made of vinyl chloride resin). A plasticizer solution was applied, and this was subjected to heat sterilization (drying) treatment and connected (4 is ε-caprolactam adhesive).

【0007】[0007]

【実施例1】ε−カプロラクタムをジ−2−エチルヘキ
シルフタレ−トに溶解し5%溶液を調整した。これを接
続チュ−ブ2の接着面に塗布してY字管3に挿入した。
その後、蒸気滅菌処理(121℃、20分)を施して接
続した。
Example 1 ε-Caprolactam was dissolved in di-2-ethylhexyl phthalate to prepare a 5% solution. This was applied to the adhesive surface of the connection tube 2 and inserted into the Y-tube 3.
After that, steam sterilization (121 ° C., 20 minutes) was performed for connection.

【0008】[0008]

【実施例2】ε−カプロラクタムをDINA(アジピン
酸ジイソノニル)に溶解し5%溶液を調整した。これを
接続チュ−ブ2の接着面に塗布して針基に挿入した。そ
の後、ギヤ−オ−プン中で加熱処理(100℃、20
分)を施して接続した。
Example 2 ε-Caprolactam was dissolved in DINA (diisononyl adipate) to prepare a 5% solution. This was applied to the bonding surface of the connection tube 2 and inserted into the needle base. Then, heat treatment (100 ° C., 20 ° C.) in a gear open
Minutes) and connected.

【0009】比較例1として、ジ−2−エチルヘキシル
フタレ−ト溶液を接続チュ−ブ2の接着面に塗布してY
字管3に挿入し、実施例1と同様に処理した。比較例2
として接続チュ−ブ2とY字管3をTHFにより接続し
た。各接続部の引張強度を引張試験機を用いて引張速度
200mm/minで、接続チュ−ブ2と接続管3をそ
れらの軸方向に引張ることで測定した。その結果を表1
に示す。
As Comparative Example 1, a solution of di-2-ethylhexyl phthalate was applied to the bonding surface of the connecting tube 2 and Y
The tube was inserted into the tube 3 and treated in the same manner as in Example 1. Comparative Example 2
The connection tube 2 and the Y-shaped tube 3 were connected by THF. The tensile strength of each connecting portion was measured by pulling the connecting tube 2 and the connecting pipe 3 in their axial direction at a pulling speed of 200 mm / min using a tensile tester. Table 1 shows the results.
Shown in

【0010】[0010]

【表1】 [Table 1]

【0011】表1の結果により、本発明の実施例1、2
は溶剤接着(比較例2)と同レベルの引張強度を有する
ことがわかる。可塑剤のみ(比較例1)では若干の引張
強度を保持することができるが、手で引き抜けない程度
の実用強度(3Kgf)には至らなかった。
According to the results shown in Table 1, Examples 1 and 2 of the present invention are shown.
Has the same level of tensile strength as that of the solvent adhesion (Comparative Example 2). The plasticizer alone (Comparative Example 1) could maintain a slight tensile strength, but did not reach a practical strength (3 kgf) such that it could not be pulled out by hand.

【0012】なお、本発明の管状部品の接着面にε−カ
プロラクタムを含む可塑剤溶液を塗布して密着させた後
の加熱処理条件は、70℃で10から30分または10
0から120℃で2から10分の範囲であれば、3Kgf
以上の実用強度をうることができることが確認できた。
また温度を120℃以上にしても引張強度は高くならな
いが、バラツキが少なく安定した強度を得ることができ
る。
The heat treatment after applying a plasticizer solution containing ε-caprolactam to the adhesive surface of the tubular component of the present invention and bringing the solution into close contact is performed at 70 ° C. for 10 to 30 minutes or 10 minutes.
3Kgf if it is in the range of 2 to 10 minutes at 0 to 120 ° C
It was confirmed that the above practical strength could be obtained.
Further, even if the temperature is set to 120 ° C. or higher, the tensile strength does not increase, but a stable strength with little variation can be obtained.

【0013】さらに本発明の安全性を確認するために溶
出物試験を行った。溶出物試験は接続チュ−ブ2とY字
管3を接続したもので、比較例として接着剤を使用しな
いものを使用した。試料として、接着剤を全く用いてい
ないY字管(比較例3)、ε−カプロラクタムで接着し
たY字管(実施例3)を用いた。
Further, an eluate test was conducted to confirm the safety of the present invention. The eluate test was performed by connecting the connecting tube 2 and the Y-shaped tube 3 and using no adhesive as a comparative example. As samples, a Y-tube without any adhesive (Comparative Example 3) and a Y-tube bonded with ε-caprolactam (Example 3) were used.

【0014】試験方法は、生物学的製剤基準の塩化ビニ
ル樹脂製血液セット基準、注射用蒸留水による溶出物試
験に順じ、試験項目は、PH差、KMn4 差について
行った。KMn4 差の試験方法は、日局プラ容器の試
験方法に順じ、基準は上記の塩化ビニル樹脂製血液セッ
ト基準(2ml未満)に準じた。その結果を表2に示
す。
The test method was in accordance with the standard for biological products, the standard for blood sets made of vinyl chloride resin, and the test for elution with distilled water for injection. The test items were PH difference and KM n O 4 difference. The method of testing KM n O 4 Sa is Ji order the test methods Japanese Pharmacopoeia Plastic containers, criteria were according to the above-mentioned vinyl resin blood set reference chloride (less than 2 ml). Table 2 shows the results.

【0015】[0015]

【表2】 [Table 2]

【0016】表2の結果より、本発明の実施例3は比較
例3と同様に、PH差、KMn4差はいずれも基準内
で安全上問題なく医療用途に適合することが確認でき
た。
[0016] than the results in Table 2, Example 3 of the present invention is similar to Comparative Example 3, PH difference, KM n O 4 difference confirmed to meet medical applications without safety problems in both the reference Was.

【0017】本発明の実施例では、管状部品として、Y
字管、接続チュ−ブ、針基を掲げたが必ずしもこれらに
限定されるものではない。また可塑剤として、ジ−2−
エチルヘキシルフタレ−ト、アジピン酸ジイソノニルを
掲げたが必ずしもこれらに限定されるものではない。
In an embodiment of the present invention, the tubular component is Y
Although the pipe, the connecting tube, and the needle base are listed, they are not necessarily limited to these. As a plasticizer, di-2-
Ethylhexyl phthalate and diisononyl adipate are listed, but are not necessarily limited thereto.

【0018】[0018]

【発明の効果】 本発明では管状部品同士の接続を充
分に保持でき、溶出物も少なく衛生的なので安心して使
用することができる。可塑剤溶液の調整と管状部品同
士への塗布、接着が容易なので組立が容易である。
According to the present invention, the connection between the tubular parts can be sufficiently maintained, the elution is small, and the sanitary parts can be used safely. Assembly is easy because adjustment of the plasticizer solution and application and adhesion between the tubular parts are easy.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の医療器具の概略図FIG. 1 is a schematic view of a medical device of the present invention.

【符号の説明】[Explanation of symbols]

1 医療器具 2 接続チュ−ブ 3 Y字管 4 ε−カプロラクタム接着剤 DESCRIPTION OF SYMBOLS 1 Medical device 2 Connection tube 3 Y-shaped tube 4 ε-caprolactam adhesive

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 管状部品同士を接続して構成される塩化
ビニル樹脂製医療器具であって、前記管状部品の接着面
にε−カプロラクタムを含む可塑剤溶液を塗布したこと
を特徴とする医療器具。
1. A medical device made of a vinyl chloride resin constituted by connecting tubular parts, wherein a plasticizer solution containing ε-caprolactam is applied to an adhesive surface of the tubular part. .
【請求項2】 請求項1記載の塩化ビニル樹脂製医療器
具の製造方法であって、前記管状部品の接着面にε−カ
プロラクタムを含む可塑剤溶液を塗布して密着させ、加
熱滅菌処理を施すことにより前記管状部品同士を接続す
ることを特徴とする医療器具の製造方法。
2. The method for producing a medical device made of a vinyl chloride resin according to claim 1, wherein a plasticizer solution containing ε-caprolactam is applied to and adhered to the adhesive surface of the tubular component, and subjected to heat sterilization. A method for manufacturing a medical device, comprising connecting the tubular components to each other.
JP03216386A 1991-08-02 1991-08-02 Medical device and method of manufacturing medical device Expired - Fee Related JP3102921B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP03216386A JP3102921B2 (en) 1991-08-02 1991-08-02 Medical device and method of manufacturing medical device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03216386A JP3102921B2 (en) 1991-08-02 1991-08-02 Medical device and method of manufacturing medical device

Publications (2)

Publication Number Publication Date
JPH0615006A JPH0615006A (en) 1994-01-25
JP3102921B2 true JP3102921B2 (en) 2000-10-23

Family

ID=16687758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03216386A Expired - Fee Related JP3102921B2 (en) 1991-08-02 1991-08-02 Medical device and method of manufacturing medical device

Country Status (1)

Country Link
JP (1) JP3102921B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH071820U (en) * 1993-06-14 1995-01-13 株式会社日研 Writing tool storage box

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3585097B2 (en) 1998-06-04 2004-11-04 セイコーエプソン株式会社 Light source device, optical device and liquid crystal display device
JP4288553B2 (en) 2000-07-25 2009-07-01 富士フイルム株式会社 Camera strobe device
KR100804653B1 (en) 2003-06-16 2008-02-20 미쓰비시덴키 가부시키가이샤 Planar light source device and display device using the same
WO2006003913A1 (en) 2004-07-06 2006-01-12 Asagicreate Co., Ltd. Surface light source and electrically illuminated signboard

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH071820U (en) * 1993-06-14 1995-01-13 株式会社日研 Writing tool storage box

Also Published As

Publication number Publication date
JPH0615006A (en) 1994-01-25

Similar Documents

Publication Publication Date Title
KR100255283B1 (en) Coextruded medical grade port tubing
JP3689486B2 (en) Multi-layer tube or sheet
US3769975A (en) Slit sleeve for preventing displacement in a catheter assembly
US3204634A (en) Surgical catheter
US6431219B1 (en) Coextruded tubing
JP3102921B2 (en) Medical device and method of manufacturing medical device
EP0826388B1 (en) Low-cost method of assembling an extruded cannula holder for a catheter insertion device
US4381008A (en) Methods of improving surface characteristics of extruded thermoplastic tubing and products produced thereby
JP2554733B2 (en) Resin tube joining method
EP0298257A1 (en) Connection for catheters, perfusion units and flasks of liquid to be perfused
JPH0546822B2 (en)
US4687474A (en) Junction for medical instruments
US4655764A (en) Medical needle assembly and medical device incorporating the same
JPS58502035A (en) Tamper-proof cannula support assembly
US4664659A (en) Medical device and method for manufacturing the same
US5135600A (en) Method for producing vinyl chloride resin products
JP3192217B2 (en) Medical tubing
JPH0280059A (en) Synthetic resin-made assembly unit and manufacture thereof
JPS6063063A (en) Production of medical device
DE4202228C2 (en) Method for gluing a hose made of hard-to-glue plastic with a tubular attachment of a plastic adapter
JPH03159655A (en) Medical utensil
JPH0213002Y2 (en)
AU1014783A (en) A method of forming a yieldable thermal bond in an autoclavable medical product implement and the like
JPH0197473A (en) Tubular member and tubular member assembly
JP2003320037A (en) Component for medical tool, and connecting method therefor

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080825

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090825

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090825

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100825

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees